{
    "nctId": "NCT01341171",
    "briefTitle": "The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Proteins",
    "officialTitle": "Platelet Modulation in the Control of Angiogenesis: The Impact of Tamoxifen and Aromatase Inhibitors on Platelet Activation and Angiogenic Proteins",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Angiogenic Protein levels",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women routinely taking tamoxifen or aromatase inhibitor therapy as prescribed by their oncologist\n\nExclusion Criteria:\n\n* Use of heparin, warfarin",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}